Introduction
Control of endometrial function is regulated externally by ovarian steroid hormones. Within the endometrium locally produced paracrine or autocrine agents may, however, mediate or modulate the effects of steroids. Growth factors, signalling peptides such as endothelins, and locally produced prostaglandins fall into this category. The endothelins may act as paracrine or autocrine agents within the endometrium for both the peptides and their receptors have been found within this tissue (Salamonsen et al., 1992; Cameron et al., 1992 Cameron et al., , 1993 Kubota et al., 1995; Marsh et al., 1996; Casey and MacDonald, 1996) .
The endothelins are a family of 21 amino acid peptides first isolated from the supernatant of cultured porcine vascular endothelial cells (Yanagisawa et al., 1988) . Three distinct peptides, endothelin 1 (ET-1), endothelin-2 (ET-2) and endothelin-3 (ET-3) have been described (Inoue et al., 1989) . ET-1 and ET-2 have potent and long-lasting vasoconstrictor activity (Yanagisawa et al., 1988; Inoue et al., 1989) . In addition to its role as a potent vasoconstrictor, ET-1 appears to be mitogenic for a variety of cells, including placental fibroblasts (Fant et al., 1992) , vascular smooth muscle cells (Kanse et al., 1995) and prostate cancer cells (Nelson et al., 1995) . Endothelins would therefore appear to have both vascular and extravascular effects.
The actions of the endothelins are mediated by binding to two distinct endothelin receptors, ET A and ET B . The ET A receptor selectively binds ET-1 and ET-2 whereas the ET B receptors binds all three endothelin isoforms with similar affinities (Arai et al., 1990; Sakurai et al., 1990) . In the human endometrium, endothelin receptors have been shown to vary throughout the menstrual cycle (Kubota et al., 1995; Collett et al., 1996) . Ligand autoradiography has been used to demonstrate that ET A receptors are present on endometrial stromal cells. The density of these receptors was greatest at mid-cycle then declined in the secretory phase. ET B receptors were, by contrast, found on glandular epithelium . In menstrual tissue, however, the ET B receptor was found on both glandular and stromal cells. These findings are consistent with the fact that the greatest abundance of ET B mRNA has been observed in menstrual tissue (Kubota et al., 1995) . The rise in ET B later in the cycle and its localization within the endometrial stroma raises the question of whether this receptor is expressed related to menstruation or whether it is associated with the onset of decidualization in the stromal cells.
Decidualization involves the differentiation of endometrial fibroblasts and the influx of bone marrow derived cells into the uterine stroma (Loke and King, 1995) . The process begins during the late secretory phase of the normal menstrual cycle and continues during pregnancy under the influence of progesterone. The stromal cells become larger in cross-section and synthesize a peri-cellular basement membrane containing collagen IV, laminin, and heparan-sulphate (Aplin et al., 1988; Aplin, 1989; Aplin and Jones, 1989) . Other biochemical changes such as the synthesis and secretion of prolactin, and the production of insulin-like growth factor binding protein 1 (Suhonen et al., 1996) have also been detected and shown to be inducible by progestagens.
The present study was undertaken to determine whether expression of endothelin receptors changes with decidualization and is correlated with the appearance of basement membrane components in the stroma. Physiological decidualization was studied in decidua of first trimester and term pregnancies and compared to specimens obtained at hysterectomy. Pharmacologically induced decidualization was assessed in a group of women with proven menorrhagia who had received synthetic progestagens (oral norethisterone or the levonorgestrel intrauterine system, Mirena ® , LNG IUS). The deposition of stromal basal membrane material was assessed immunohistochemically using antibodies against laminin-α 2 light chain and collagen type IV, markers of decidualization (Aplin et al., 1995) .
Materials and methods
Informed consent was obtained from every patient. Each aspect of the study was approved by the local Ethical Committees.
Collection of decidua and endometrium
Decidual tissue was collected from 15 healthy women with normal pregnancies undergoing surgical termination of pregnancy during the weeks 7-11 of gestation. Decidua was also obtained from the basal plate from 10 placentas delivered at term (gestation at delivery 38 Ϯ 2 weeks). The specimens were collected within 10 min and snap-frozen in liquid nitrogen and stored at -70°C until further use.
Biopsies were collected from 18 women with regular menstrual cycles and objectively measured menorrhagia (menstrual blood loss Ͼ80 ml per month). Biopsies were taken before and after treatment with progestagens administered to control excessive bleeding. Blood loss was measured in one cycle prior to treatment by the alkaline haematin method (Hallberg and Nilsson, 1964) . Endometrial biopsies were taken using a Z-Sampler endometrial suction curette (Zinnanti, Chatsworth, CA, USA) at a median of 21 days (range 19-25) after the onset of menstruation during a pre-treatment control cycle. A total of 10 women subsequently received oral norethisterone (5 mg three times daily from days 5-26 of the cycle) and eight received levonorgestrel, via the levonorgestrel intrauterine system (LNG IUS, Mirena ® ; Leiras Oy, Turku, Finland). The LNG IUS, which releases 20 µg LNG daily, was inserted within 5 days of the onset of menstruation. A second, post-treatment, biopsy was taken after a median of 18 days (range 13-24) exposure to levonorgestrel or 17 days (range 15-21) exposure to norethisterone. Blood loss was measured again in the menstrual cycle immediately following com-186 mencement of treatment. Tissue was obtained, not as a solid block, but as a mixture of small fragments originating mostly from the stratum functionalis. Only eight of the 10 biopsies from the women treated with norethisterone were of sufficient quality for analysis. The group from whom biopsies were taken represents a subset of a larger cohort of progestagen treated patients whose characteristics and treatment response have been described in more detail elsewhere (Irvine et al., in press ).
Endometrial biopsies with attached myometrium were collected from 15 healthy women undergoing hysterectomy for benign disease. Histological assessment of endometrial morphology was carried out according to standard criteria (Noyes et al., 1950) .
Immunohistochemistry
Cryostat sections were fixed in acetone at 4°C for 10 min, air-dried and rinsed in phosphate-buffered saline (PBS; pH 7.4) for 10 min. In first trimester tissue, stromal cells were identified with a polyclonal antibody against vimentin (Euro-Path Ltd, Bude, UK). Glands and extravillous trophoblast were localized using a monoclonal antibody against cytokeratins (clone MNF 116; Dako, High Wycombe, UK). Deposition of stromal basement material was assessed with monoclonal antibodies against laminin α 2 light chain (anti-human merosin, clone 5H2; Gibco BRL, Paisley, UK) (Leivo et al., 1989; Church et al., 1996) and collagen type IV (Sigma, Poole, UK). The sections were pre-incubated for 20 min in PBS supplemented with 1.5% (w/ v) bovine serum albumin (BSA). The primary antibodies were applied for 60 min (anti-cytokeratin 1:400, anti-vimentin 1:130, anti-laminin α 2 light chain 1:900, anti-collagen type IV 1:1000) diluted in PBS supplemented with 1.5% (w/v) BSA. After washing in PBS for 3ϫ5 min, biotinylated rabbit anti-mouse (1:500, Dako) or biotinylated goat-anti rabbit (Vector, Peterborough, UK) secondary antibody were applied for 30 min. Sections were then incubated in 1% H 2 O 2 in absolute methanol for 10 min to inactivate endogenous peroxidase followed by incubation with streptavidin-peroxidase-conjugate (StreptAB-complex/HRP, Dako) for 20 min. The streptavidin-biotin complex was visualized with 3,3 diaminobenzidine tetrahydrochloride (Sigma). Control sections were either incubated in PBS without primary antibody or with a mouse monoclonal antibody IgG1 against glucose oxidase from Aspergillus niger (Dako), an enzyme which is not present in mammalian tissue. Control sections did not show any immunostaining.
Western blotting
Laminin was extracted from first trimester decidual tissue and analysed by procedures already described in detail elsewhere (Church et al., 1996) . The tissue was homogenized in the presence of protease inhibitors and extracted with 0.5% sodium deoxycholate until all traces of blood were removed. The homogenate was digested with collagenase (Type VII, Sigma), centrifuged at 18 000 g for 1 h at 4°C and the supernatant collected. The pellet was then extracted in 10 mM EDTA containing protease inhibitors, centrifuged, and the resulting pellet discarded. Both supernatants were pooled and precipitated with ammonium sulphate (300 g/l) at 4°C and the pellet recovered by centrifugation. The pellet was re-suspended in PBS containing protease inhibitors and dialysed against PBS. Samples (10 µg) of the extract were analysed under reducing conditions by sodium dodecyl sulphate-polyacrylamide gel elecetrophoresis (SDS-PAGE) on 5% gels. Proteins were transferred to nitrocellulose (Problott, Applied Biosystems, Warrington, UK) and the membrane was blocked with 5% dried milk in Tris-buffered saline, 0.05% Tween 20). The blot was probed for laminin α 2 light chain with the same antibody used for immunocytochemistry (clone 5H2). Antibody binding was detected with an anti-mouse alkaline phosphatase conjugate (Dako) and NBT-BCIP substrate (BioRad, Hemel Hempstead, UK).
Autoradiography
Previous studies have shown that quantitative autoradiographic localization of ET ligand binding sites is a valid measure of receptor distribution in the uterus (Bacon et al., 1995) . Macroautoradiography was carried out to provide quantification of ligand binding by the use of ET receptor selective ligands. Serial cryostat sections (10 µm) were cut at -21°C, mounted onto slides coated with 3-aminopropyltriethoxysilane (Sigma), air-dried for 30 min at room temperature (RT) and stored at -70°C. After thawing, sections were preincubated for 15 min in a buffer containing 50 mM HEPES, 5 mM MgCl 2 and 0.3% BSA (Sigma), pH 7.4 at RT. The slides were then incubated in HEPES buffer containing 100 pM [ 125 I]-PD151242 (ET A antagonist) or [ 125 I]-BQ3020 (ET B agonist) (Amersham, Chalfont, UK) for 2 h at RT. In control sections non-specific binding was assessed by incubating [ 125 I]-labelled ligand in the presence of excess (1 µM) of the corresponding unlabelled molecule. Unbound ligand was removed by washing the sections in 0.05 M Tris buffer, pH 7.4 (Sigma) for 3ϫ15 min at 4°C. The sections were briefly rinsed in distilled water at 4°C, fixed for 10 min in 4% neutral-buffered paraformaldehyde at 4°C, rinsed in distilled water at 4°C and then air-dried. Macroautoradiographic images were produced by exposing the dry labelled sections to photographic film (Hyperfilm-beta max; Amersham) together with [ 125 I]-labelled external standards (Microscales; Amersham) for 115 h at room temperature. The autoradiographic film was developed for 6 min (D-19; Kodak, Hemel Hempstead, UK). Control sections which had been co-incubated with an excess of unlabelled ligand did not reveal any non-specific binding.
The sections were then covered with liquid photographic emulsion for microautoradiographic localization of ligand binding. Fixation of the labelled sections in 4% neutral buffered paraformaldehyde preserved tissue morphology and prevented dissociation of ligand before coating the dried sections with a thin film of emulsion (EM-1; Amersham), applied with a wire loop at 42°C. Slides were stored in the dark at 4°C for 9 days and developed for 5 min (D-19; Kodak). Sections were counterstained with 0.2% Toluidine Blue in 30% ethanol and mounted in DPX-mounting medium (BDH, Lutterworth, UK). Silver grains were visualized by either epipolarization microscopy or tangential illumination with a conventional fibre-optic probe (Highlight 300, Olympus).
Quantitative analysis of macroautoradiographs
Quantitative densitometric analysis of the macroautoradiographic film images was carried out on specimens of first trimester decidua using an image analysis system (MCID; Imaging Research Inc, St. Cathrine's, Ontario, Canada). Film exposure was calibrated against the [ 125 I]-labelled external standards (Microscales; Amersham) and a calibration curve was calculated with a cubic spline function. The density of ligand binding was then expressed in amol/mm 2 .
The aim of the analysis was to discover whether obvious variations in laminin expression within one section were associated with variations in receptor density in autoradiographs produced from two parallel sections. As it was not possible to provide external densitometric calibration of laminin staining, regions of the tissue were selected where laminin was either very abundant in the stroma or very sparse. The autoradiographs were aligned by computer using a bit-subtraction method. Alignment ensured that measurements were made in approximately the same areas for each receptor. Five measurements were taken in areas that corresponded to the laminin abundant regions and another five that corresponded to laminin sparse 187 regions. The difference in receptor density between laminin abundant and laminin sparse regions was then compared statistically.
In nine first trimester tissues where macroscopically obvious variations in laminin expression existed a regression analysis was undertaken. Three statistical models of increasing complexity were used to determine whether changes in the expression of each receptor were correlated with the abundance of laminin in the stroma. In model 1 the data were pooled and the differences between patients were ignored. In models 2 and 3 individual patients were used as 'dummy' (or predictor) variables, so that significance of differences between individual samples could be assessed.
Model 1: ET laminin-abundant ϭ α ϩ ET laminin-sparse ϩ random variation Model 2: ET laminin-abundant ϭ α i ϩ βET laminin-sparse ϩ random variation Model 3: ET laminin-abundant ϭ α i ϩ β i ET laminin-sparse ϩ random variation where ET denotes the calibrated binding density for the ET A or ET B ligand, i denotes the ith patient, α, in model 1, denotes the mean difference in ET between laminin-sparse and lamininabundant areas, α i , in model 2 and 3, denote the different mean basal levels of ligand binding in laminin-sparse areas for the different patients, β denotes the magnitude of ET change after decidualization. In model 3, β is assumed to vary between patients.
The values for α and β were calculated using an analysis of variance for model 1 or by multiple regression analysis using a matrix of predictor variables for models 2 and 3 (Minitab, version 10.5). F ratios, and the associated P values, were also calculated to determine whether or not the more complex theoretical models provided a significantly better fit to the data (Snedecor and Cochran, 1967) .
The relationship between binding of the ET A and ET B ligands was examined by multiple regression analysis using the same approach to that described above. Two models were compared; one equivalent to model 3 and another in which the α i terms were absent.
In six of the 15 first trimester specimens laminin α 2 expression was intense but macroscopically uniform. These specimens were excluded from the statistical analysis referred to above. Data from these specimens were, however, collected to allow comparison with the specimens in which matrix deposition varied and previously published ligand binding densities in endometrium obtained from patients undergoing hysterectomy . A one-way analysis of variance was also carried out for each receptor to determine whether or not there were significant differences between patients (Minitab, version 10.5).
Results
Laminin α 2 light chain and collagen type IV expression in endometrium and decidua
In endometrium obtained from hysterectomy specimens, collagen type IV ( Figure 1A ) and laminin α 2 light chain were found in the basement membranes of the glandular and luminal epithelium, the microvascular endothelium and vascular smooth muscle cells. The stroma had limited, punctate, expression of the basement membrane proteins during the proliferative phase of the cycle. In the late secretory phase more widespread expression was found around decidualized stromal cells, par- ticularly in peri-arteriolar and peri-luminal regions underlying the surface epithelium. Pre-treatment biopsies obtained from women with proven menorrhagia exhibited a similar pattern.
After~3 weeks exposure to intra-uterine or oral progestagens, laminin α 2 light chain was more widely distributed within the stroma. Expression within the vascular and epithelial basement membranes was apparently unaltered. In some regions of the endometrial stroma, particularly tissue exposed to intra-uterine progestagen, laminin α 2 entirely surrounded individual cells ( Figure 1B) . In other regions, expression of the basement membrane protein in the stroma was similar to that found in the pre-treatment luteal phase biopsies or in the endometrium of hysterectomy patients.
In first trimester decidua, collagen type IV and laminin α 2 light chain were widely distributed within the stroma and were also present in the basement membranes of cytokeratin positive glands, and vascular smooth muscle and endothelium ( Figure 1C,D) . Expression within the vimentin immunoreactive stroma was highly variable. Some areas were similar to the high abundance regions seen after brief intra-uterine progestagen exposure. In other areas stromal basement membrane was much more sparse and thus similar to that observed in proliferative or secretory phase endometrium. Western blotting of a decidual extract confirmed the specificity of the laminin α 2 light chain antibody (Figure 2 ). BQ3020, on macro-and microautoradiographs. The ET A ligand bound to stromal cells but not glands. ET B ligand was found at high density on glandular epithelium and was variably expressed in the stroma. It was not possible to determine whether ET A and ET B ligand binding sites were present on blood vessels because of the high level of stromal expression and the limited resolution of microautoradiography.
ET ligand binding to first and third trimester decidua
A high density of ET A and ET B ligand binding was observed in the 6 first trimester specimens with uniformly high laminin α 2 light chain expression (Table I) . One way analysis of variance demonstrated significant variability in both ET A and ET B binding densities between patients (P Ͻ 0.001).
In the remaining nine specimens obvious variations in collagen IV and laminin α 2 could be identified. Macro-and microautoradiography demonstrated a high density of ET A throughout the tissue and a higher density of ET B ligand binding in collagen IV and laminin-abundant areas ( Figure 3A ,B,C). Quantitative analysis revealed a highly significant correlation between ET B ligand binding and laminin α 2 light chain expression for each patient (Table II and Figure 4 ). By contrast, there was no consistent correlation between the density of ET A ligand binding and laminin α 2 light chain expression (Table III) . There were, however, significant differences in the density of ligand binding between patients for both ET A and ET B . Interpatient variability was present both in the laminin-sparse and laminin-abundant areas. These conclusions are based on the fact that model 3 provided a significantly better theoretical fit to the data than model 2 (ET A , F ϭ 25.24, P Ͻ 0.01; ET B , F ϭ 22.9, P Ͻ 0.01), although model 2 was significantly better than model 1.
In a separate analysis of the relationship between ET A and ET B, ligand binding for both receptor types was not found to be significantly correlated, either in the laminin-sparse or laminin-abundant areas (Figure 4) . Separate multiple regression analysis for each type of area did not reveal a consistent pattern of correlation for individual patients that might have been masked within the pooled data set (analysis not shown).
Qualitative assessment of small areas of third trimester decidua in microautoradiographs demonstrated a similar binding density for ET B receptor whereas ET A receptor density appeared much lower than that found in the first trimester.
Blood loss and ET ligand binding after progestagen exposure
Progestagen administration to women with proven menorrhagia produced significant and substantial reductions in blood loss. After 21 days exposure to oral norethisterone median blood loss was reduced from 128 ml [95% confidence interval (CI) 93.3-190.4 ] to 51.5 ml (95% CI 25.5-148.2). After 26 days exposure to the intrauterine L-norgestrel releasing system blood loss declined from 100.5 ml (95% CI 97.6-123.7) to 16 ml (95% CI 3.7-28.0). Blood loss before treatment was not significantly different between the groups (P ϭ 0.267, Mann- Figure 1C. (B) The macroautoradiograph of a parallel section illustrates that ET A receptor is distributed in areas where stromal basement membrane is sparse and in areas where it is abundant (C) ET B receptor density is highest in the area on the right where more collagen IV was also found. Scale bar ϭ 100 µm.
Whitney test).
After treatment with intrauterine L-norgestrel blood loss was significantly lower than that measured following treatment with oral norethisterone (P ϭ 0.02).
In pre-treatment control biopsies, ET A ligand binding was present in stromal cells but not in the surface epithelium or the superficial areas of the glands. The surface epithelium was consistently negative for ET B . Glandular binding of the ET B agonist was observed in one of eight L-norgestrel treated biopsies in which more basal glandular epithelium was sampled.
After treatment, ET B ligand binding was observed in the stroma of each of the eight specimens treated with intra-uterine levonorgestrel and in seven out of eight specimens treated with oral norethisterone. Comparison of the microautoradiographic slides and parallel tissue sections in which laminin α 2 light Figure 4 . The relationship between ET A and ET B is illustrated for laminin-sparse (s) and laminin-abundant (j) areas of the first trimester decidua. ET B expression increased with laminin abundance although ET A did not change. The pooled data set showed no significant correlation between the expression of both receptor types although each receptor was sampled at equivalent points in consecutive cryosections. Table II . Calibrated ET B ligand binding densities in laminin-sparse and laminin-abundant areas of decidua. The regression analysis of the relationship between laminin expression and ET B density for model 3 is illustrated. The regression coefficients α i and β i and the associated P values for each individual are shown. α represents the level of expression in the laminin-sparse areas. β represents the magnitude of change in expression between laminin-sparse and lamininabundant areas. P is the probability that the correlation for a particular patient occurred by chance. The β values were consistently positive and highly significant thus demonstrating a clear relationship between ET B and matrix deposition *The outcome of the analysis was not changed when logarithmic transformation of the data was used to minimize any effect of difference in variance between patients. Table III . Calibrated ET A ligand binding densities in laminin-sparse and laminin-abundant areas of decidua. The regression analysis of the relationship between laminin expression and ET A density for model 3 is illustrated. The regression coefficients α i and β i and the associated P values for each individual are shown. Negative values of coefficients represent inverse correlations. α represents the level of expression in the laminin-sparse areas. β represents the magnitude of change in expression between laminin-sparse and laminin-abundant areas. P is the probability that the correlation for a particular patient occurred by chance. The β values were neither consistently positive nor significant thus suggesting the lack of a relationship between ET A and matrix deposition 
Discussion
This study has demonstrated that both ET A and ET B receptors are expressed in the decidualized endometrial stroma during pregnancy or following exposure of the endometrium to high doses of exogenous progestagens In previous studies the endometrial distribution of ET A and ET B was examined during the menstrual cycle and in term decidua (Rutherford et al., 1993; Kohnen et al., 1996) . It is now clear that cyclic variations of the ET receptor expression reported in previous studies may arise in Figure 5 . (A) Laminin α 2 light chain distribution in an endometrial biopsy taken after exposure to intrauterine levonorgestrel. There is abundant laminin deposition on the decidualized stroma (ds) on the right (B) Tangential fibre optic illumination of a microautoradiograph from a parallel section reveals that ET B receptor (bright area) co-distributes with laminin α 2 light chain. Scale bar ϭ 100 µm.
part due to the effect of fluctuations in endogenous progesterone.
Previously ET A receptors were found to be present in the non-decidualized stroma and to be maximally expressed around mid-cycle. The present study shows that after decidualization ET A is expressed in the stroma at a level comparable with that previously observed in the luteal phase .
In non-pregnant endometrium ET B was present in the glandular epithelium. Within the basal layer ET B was elevated throughout the luteal phase. Epithelium within the superficial, or functional, layer expressed this receptor only in the later part of the cycle. Both of these observations suggest that progesterone may also regulate ET receptor expression in the epithelium.
At the time of menstruation ET B was also present in the stroma. Receptor density increased in the superficial (functional) layer to a level that may have been similar to, or greater than, that found in the endometrial stroma after decidualization. Whether the rise in endometrial ET B ligand binding at the end of the cycle is associated with the onset of menstruation or is due to the start of decidualization has yet to be determined. It is noteworthy, however, that during menstruation and decidualization ET B is present in the stroma. Once the function of the receptors within the stroma becomes known it may be possible to deduce whether stromal ET B is directly involved in menstruation or merely heralds the start of decidualization.
The finding of ET B receptor in term decidua with small amounts of ET A receptor is in keeping with previous findings (Rutherford et al., 1993; Kohnen et al., 1996) . Due to the small number of decidual cells present in the specimens obtained from term placentae only qualitative assessment of receptor distribution could be performed. Nevertheless, the current qualitative findings suggest, a reduction of ET A in term 191 decidua compared to first trimester decidua. The role of endothelins in first and third trimester may therefore be different.
The present findings highlight the fact that decidualization should not be treated as a phenomenon occurring uniformly throughout the tissue. Heterogeneity of matrix production and receptor distribution were observed during pregnancy and also after administration of high dose progestagens. It therefore seems unlikely that the amount of hormonal stimulus is responsible for heterogeneity within the tissue or for differences between women. Markers of stromal basement membrane deposition, such as collagen type IV, laminin and heparan sulphate (Aplin et al., 1988; Aplin, 1989; Aplin and Jones 1989) , provide a valuable way of identifying that heterogeneity. Recently, expression of laminin α 2 -containing isoforms were observed to be up-regulated (Church et al., 1996) . It is now clear from immunocytochemistry, and verification of antibody specificity by Western blotting, that laminin α 2 is also present in the non-stromal basement membranes of cycling endometrium (epithelium, endothelium and vascular smooth muscle). The α 2 chain of laminin is thus a less specific marker of decidualization than it first appeared to be (Church et al., 1996) . The spatial correlation between ET B receptor and stromal basement membrane distribution suggests that regulation of the ET B receptor gene in endometrial stromal cells may be hormonally controlled in a similar way to other markers of decidualization. Northern analysis of decidual cell cultures may reveal whether the receptor is controlled at the level of gene expression or at a post-transcriptional stage.
In the current examination of menorrhagic patients, menstrual blood loss was markedly reduced after brief progestagen exposure in 16 out of the 18 patients. Up-regulation of ET B receptor or changes in the supporting extracellular matrix of the stroma during decidualization could have contributed to this functional change, although the mechanism remains unclear. Investigation of effects on blood vessels was limited by the fact that aspiration biopsy preferentially samples the superficial layers of the endometrium and so did not give any information about the distribution of ET A or ET B receptors in the basal region. Experimental observation in the macaque suggests that vasoconstriction of the basal spiral arterioles contributes to the control of bleeding at the time of menstruation (Markee, 1940) .
In order to determine what function the endothelins exert on the stroma it will be necessary to identify which populations of cells express the receptor. In the present study the correlation of stromal basement membrane deposition and the patterns of ET receptor expression observed by micro-and macroautoradiography suggested that the decidualized stromal fibroblasts express both receptors. Cell isolation or immunolocalization with receptor-specific antibodies will be required to determine whether or not other cell populations such as uterine natural killer cells, endothelial cells or vascular smooth muscle cells may also be susceptible to the effects of endothelins.
Little is known about the molecular role of endothelins and their receptors in decidualized tissue. Previous immunocytochemical observations suggest that endothelins may be produced by decidual cells (van Papendorp et al., 1991) . Synthesis and release of endothelin-1 has been demonstrated in cultures of human first trimester decidual cells (Kubota et al., 1992) . Addition of ET-1 to cultures of first trimester decidual cells has been shown to modulate the release of prolactin (Chao et al., 1993) , although ET A and ET B receptors may act through different second messenger systems in these cells (Seki et al., 1995) . The presence of ET A and ET B receptors and production of ET-1 (van Papendorp et al., 1991; Maggi et al., 1994) within the decidua suggests that endothelins may play a paracrine or autocrine role in decidual cells throughout pregnancy. The vasodilatory effect of the ET peptides has been linked to the release of nitric oxide (NO) and prostacyclin mediated via ET B (de Nucci et al., 1988; Hirata and Emori, 1993; Davenport and Maguire, 1994) . It seems possible that the vascular paradigm might also apply to the decidualized stromal cells for these have also been shown to express inducible nitric oxide synthase (Telfer et al., 1997) . Endothelins acting via the ET B receptor might therefore promote the release of NO from decidualized fibroblasts as well as vascular smooth muscle cells.
Paracrine signalling involving the endothelin receptors might also be important in the interaction between trophoblast and decidua. A preliminary report of cell culture experiments suggests that ET-1 regulates the invasion of extravillous trophoblast via ET B receptors, while proliferation is regulated by both ET A and ET B (Cervar et al., 1997) . A paracrine action of this nature could regulate the invasion of extravillous trophoblast and even affect placental growth particularly during implantation.
Although the biological function of endothelins within the decidua remains unknown, it is now clear that the ET B receptor expression, like other decidual cell characteristics, is modified in pregnancy or after exposure to progestagens.
